Device Orthopedic Device

Balanced Knee System

Payments companies reported to CMS as associated with Balanced Knee System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.4Massociated payments (2023-2025)
98clinicians with associated payments
2companies reporting

By year

2023 $414K
2024 $1.5M
2025 $555K

Payments reported as associated with Balanced Knee System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1.5M
Adult Reconstructive Orthopaedic Surgery $933K
Sports Medicine (Orthopaedic Surgery) $2,662
Surgical $1,450
Internal Medicine $1,136
Pediatric Orthopaedic Surgery $612

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Balanced Knee System

These are the largest totals companies reported as associated with Balanced Knee System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Calton Washington Terrace, UT Orthopaedic Surgery $1,005,101.99
Nathan Momberger Murray, UT Adult Reconstructive Orthopaedic Surgery $530,701.58
Friedrich Boettner New York, NY Adult Reconstructive Orthopaedic Surgery $398,126.03
Michael Langworthy North Dartmouth, MA Orthopaedic Surgery $247,092.97
Manish Patel Franklin, VA Orthopaedic Surgery $178,993.87
Joshua Hickman Bountiful, UT Orthopaedic Surgery $13,000.00
Kevin Terefenko Wyomissing, PA Orthopaedic Surgery $9,043.47
Clint Wooten Bountiful, UT Orthopaedic Surgery $7,250.00
Matthew Barber Mobile, AL Orthopaedic Surgery $4,907.67
Jeffrey Frandsen Charlotte, NC Orthopaedic Surgery $3,126.19

Prescribed Balanced Knee System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.